Publication | Open Access
EZH2‐mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ
46
Citations
42
References
2021
Year
KLF14 exerts a critical anti-fibrotic role in liver fibrosis, and targeting the EZH2/KLF14/PPARγ axis might be a novel therapeutic strategy for liver fibrosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1